Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23570634 | 0.88 | EGFR (0.62) | EGFRERBB2 | |
| SCHEMBL30140336 | 0.88 | ERBB2 (0.49) | EGFRERBB2 | |
| SCHEMBL30140465 | 0.87 | EGFR (0.71) | EGFRERBB2 | |
| SCHEMBL30140237 | 0.86 | EGFR (0.69) | EGFRERBB2 | |
| SCHEMBL30140119 | 0.86 | EGFR (0.56) | EGFRERBB2 | |
| SCHEMBL30140179 | 0.83 | EGFR (0.58) | EGFRERBB2 | |
| SCHEMBL23537821 | 0.82 | EGFR (0.78) | EGFRERBB2 | |
| SCHEMBL23537818 | 0.82 | EGFR (0.78) | EGFRERBB2 | |
| SCHEMBL30140253 | 0.82 | EGFR (0.68) | EGFRERBB2 | |
| SCHEMBL23537834 | 0.82 | EGFR (0.69) | EGFRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022266426-A1 | 6-(HETEROCYCLOALKYL-OXY)-QUINAZOLINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2022-12-22 | — | — | WO | disclosed |